Cargando…

Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis

BACKGROUND: Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZH), and to investigate the underlying mechanisms by integrating transcriptional...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xiangying, Liu, Yudong, Li, Congchong, Mao, Xia, Xu, Tengteng, Hu, Zhixing, Zhang, Chu, Lin, Na, Lin, Ya, Zhang, Yanqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246043/
https://www.ncbi.nlm.nih.gov/pubmed/37280673
http://dx.doi.org/10.1186/s12935-023-02946-2
_version_ 1785054967254482944
author Yan, Xiangying
Liu, Yudong
Li, Congchong
Mao, Xia
Xu, Tengteng
Hu, Zhixing
Zhang, Chu
Lin, Na
Lin, Ya
Zhang, Yanqiong
author_facet Yan, Xiangying
Liu, Yudong
Li, Congchong
Mao, Xia
Xu, Tengteng
Hu, Zhixing
Zhang, Chu
Lin, Na
Lin, Ya
Zhang, Yanqiong
author_sort Yan, Xiangying
collection PubMed
description BACKGROUND: Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZH), and to investigate the underlying mechanisms by integrating transcriptional regulatory network analysis and experimental validation. METHODS: A diethylnitrosamine (DEN)-induced HCC model in rats was established and used to evaluate the anti-cancer efficacy of PZH. After detecting a transcriptomic profiling, the “disease-related gene–drug effective target” interaction network was constructed, and the candidate targets of PZH against malignant transformation from hepatic fibrosis to HCC were identified and verified in vitro. RESULTS: PZH effectively alleviated the pathological changes of hepatic fibrosis and cirrhosis, and inhibited tumor formation and growth in DEN-induced HCC rats. Additionally, the administration of PZH reduced the levels of various hepatic function-related serological indicators significantly. Mechanically, a ferroptosis-related SLC7A11-GSH-GPX4 axis might be one of potential targets of PZH against malignant transformation from hepatic fibrosis to HCC. Especially, high SLC7A11 expression may be associated with poor prognosis of HCC patients. Experimentally, the administration of PZH markedly increased the trivalent iron and ferrous ion, suppressed the expression levels of SLC7A11 and GPX4 proteins, and reduced the GSH/GSSG ratio in the liver tissues of DEN-induced HCC rats. CONCLUSIONS: Our data offer an evidence that PZH may effectively improve the hepatic fibrosis microenvironment and prevent the occurrence of HCC through promoting ferroptosis in tumor cells via inhibiting the SLC7A11-GSH-GPX4 axis, implying that PZH may be a potential candidate drug for prevention and treatment of HCC at an early stage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02946-2.
format Online
Article
Text
id pubmed-10246043
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102460432023-06-08 Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis Yan, Xiangying Liu, Yudong Li, Congchong Mao, Xia Xu, Tengteng Hu, Zhixing Zhang, Chu Lin, Na Lin, Ya Zhang, Yanqiong Cancer Cell Int Research BACKGROUND: Malignant transformation from hepatic fibrosis to carcinogenesis may be a therapeutic target for hepatocellular carcinoma (HCC). The aim of this study was to evaluate anti-cancer efficacy of Pien-Tze-Huang (PZH), and to investigate the underlying mechanisms by integrating transcriptional regulatory network analysis and experimental validation. METHODS: A diethylnitrosamine (DEN)-induced HCC model in rats was established and used to evaluate the anti-cancer efficacy of PZH. After detecting a transcriptomic profiling, the “disease-related gene–drug effective target” interaction network was constructed, and the candidate targets of PZH against malignant transformation from hepatic fibrosis to HCC were identified and verified in vitro. RESULTS: PZH effectively alleviated the pathological changes of hepatic fibrosis and cirrhosis, and inhibited tumor formation and growth in DEN-induced HCC rats. Additionally, the administration of PZH reduced the levels of various hepatic function-related serological indicators significantly. Mechanically, a ferroptosis-related SLC7A11-GSH-GPX4 axis might be one of potential targets of PZH against malignant transformation from hepatic fibrosis to HCC. Especially, high SLC7A11 expression may be associated with poor prognosis of HCC patients. Experimentally, the administration of PZH markedly increased the trivalent iron and ferrous ion, suppressed the expression levels of SLC7A11 and GPX4 proteins, and reduced the GSH/GSSG ratio in the liver tissues of DEN-induced HCC rats. CONCLUSIONS: Our data offer an evidence that PZH may effectively improve the hepatic fibrosis microenvironment and prevent the occurrence of HCC through promoting ferroptosis in tumor cells via inhibiting the SLC7A11-GSH-GPX4 axis, implying that PZH may be a potential candidate drug for prevention and treatment of HCC at an early stage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02946-2. BioMed Central 2023-06-06 /pmc/articles/PMC10246043/ /pubmed/37280673 http://dx.doi.org/10.1186/s12935-023-02946-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yan, Xiangying
Liu, Yudong
Li, Congchong
Mao, Xia
Xu, Tengteng
Hu, Zhixing
Zhang, Chu
Lin, Na
Lin, Ya
Zhang, Yanqiong
Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
title Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
title_full Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
title_fullStr Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
title_full_unstemmed Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
title_short Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
title_sort pien-tze-huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting slc7a11-gsh-gpx4 axis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246043/
https://www.ncbi.nlm.nih.gov/pubmed/37280673
http://dx.doi.org/10.1186/s12935-023-02946-2
work_keys_str_mv AT yanxiangying pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT liuyudong pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT licongchong pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT maoxia pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT xutengteng pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT huzhixing pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT zhangchu pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT linna pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT linya pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis
AT zhangyanqiong pientzehuangpreventshepatocellularcarcinomabyinducingferroptosisviainhibitingslc7a11gshgpx4axis